Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3THM

Crystal structure of Fas receptor extracellular domain in complex with Fab EP6b_B01

Summary for 3THM
Entry DOI10.2210/pdb3thm/pdb
Related3TJE
DescriptorFab EP6b_B01, light chain, Fab EP6b_B01, heavy chain, Tumor necrosis factor receptor superfamily member 6, ... (6 entities in total)
Functional Keywordsagonistic antibody, fab fragment, antibody-receptor complex, tumor necrosis factor receptor, cysteine-rich domain, fas, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight67705.36
Authors
Zuger, S.,Stirnimann, C.,Briand, C.,Grutter, M.G. (deposition date: 2011-08-19, release date: 2012-05-09, Last modification date: 2024-11-06)
Primary citationChodorge, M.,Zuger, S.,Stirnimann, C.,Briand, C.,Jermutus, L.,Grutter, M.G.,Minter, R.R.
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency.
Cell Death Differ., 19:1187-1195, 2012
Cited by
PubMed Abstract: Receptor agonism remains poorly understood at the molecular and mechanistic level. In this study, we identified a fully human anti-Fas antibody that could efficiently trigger apoptosis and therefore function as a potent agonist. Protein engineering and crystallography were used to mechanistically understand the agonistic activity of the antibody. The crystal structure of the complex was determined at 1.9 Å resolution and provided insights into epitope recognition and comparisons with the natural ligand FasL (Fas ligand). When we affinity-matured the agonist antibody, we observed that, surprisingly, the higher-affinity antibodies demonstrated a significant reduction, rather than an increase, in agonist activity at the Fas receptor. We propose and experimentally demonstrate a model to explain this non-intuitive impact of affinity on agonist antibody signalling and explore the implications for the discovery of therapeutic agonists in general.
PubMed: 22261618
DOI: 10.1038/cdd.2011.208
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227933

PDB entries from 2024-11-27

PDB statisticsPDBj update infoContact PDBjnumon